The Effect of Post-Cesarean Section Acupressure on the Severity of Pain and First Mobilization Distance

NCT05311449 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2022-09-27

No results posted yet for this study

Summary

This randomized controlled trial evaluates the effect of acupressure application on cesareans' pain and the number of steps in the first mobilization. This study hypothesizes that acupressure reduces pain and improves number of steps.

Conditions

Interventions

OTHER

Acupressure

The experimental group will start with LI4 points, and continue with P6 and SP6 points. The application will be carried out by determining the priority order of the points with the draw. Attention will be paid to the intensity and duration of the pressure deemed appropriate. Since the individuals' responses will differ, the stiffness and pressure will be adjusted according to the individual's sensitivity not to cause tissue damage. Before starting the application, around the area to be pressed for 20-30 seconds will be gently rubbed with palm. With the gentle rubbing of the surrounding tissue, the tension and tissue sensitivity in warming, relaxing and preparatory will be reduced, and the tissue will be relieved. After, the point determined will be pressed manually for 2 minutes.

OTHER

Plasebo acupressure

In the control group, the application will start with the points 1.5 cm around the LI4, P6 and SP6 points. The application process will continue in the same way with acupressure group and the pressure intensity will be less.

Sponsors & Collaborators

  • Mersin University

    lead OTHER

Principal Investigators

  • Duygu VEFİKULUÇAY YILMAZ, Doctorate · Mersin University

  • Aslıhan AKSU, master · Mersin University

  • Filiz DEĞİRMENCİ, master · Mersin University

  • Gülay ALTUN UĞRAŞ, doctorate · Mersin University

  • Mürşide ÇEVİKOĞLU KILLI, doctorate · Mersin City Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-26
Primary Completion
2022-06-26
Completion
2022-07-22

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05311449 on ClinicalTrials.gov